MedTrace Logo

Biomarkers for the Early Identification of Sepsis in the Emergency Department

NCT02707718 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2018-04-17

No results posted yet for this study

Summary

Monocentric prospective study on consecutive patients attending the emergency department and suspected to have sepsis. Blood sampling for the measurement of a panel of biomarkers of interest in sepsis.

Conditions

Interventions

BIOLOGICAL

blood sampling

during the usual blood sampling performed in the ED in patients suspected of sepsis, two additional tubes will be sampled for a panel of biomarkers measurement

Sponsors & Collaborators

  • Institut Pasteur

    collaborator INDUSTRY

  • Bio-Rad Laboratories

    collaborator INDUSTRY

  • Pitié-Salpêtrière Hospital

    lead OTHER

Principal Investigators

  • pierre Hausfater, Md PhD · ARCEAR

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2018-03-03
Completion
2018-03-03

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02707718 on ClinicalTrials.gov